Cervical cancer ranks as the second most prevalent form of the deadly disease among women in Rwanda, yet only 24 percent of eligible females in the country have undergone screening in the past five years, according to the Rwanda Health Management Information System (HMIS).
To address this Chinese BGI Genomics (Beijing Genomics Institute) and the Rwanda Biomedical Centre (RBC) have launched a pioneering cervical cancer screening programme in Ngoma District, Eastern Province.
